The BFS syringe market was valued at US$406.801 million in 2022.
The healthcare and cosmetics industries' rising need for BFS syringes is anticipated to fuel market expansion. The market demand is being driven by the choice of modern pharmaceutical packaging types and unit dosage packaging. Pharmaceutical businesses utilize prefilled syringes with blow-fill seal (BFS) technology. Throughout the projection period, a considerable increase in the market for BFS syringes is anticipated as a result of this. Aseptic packaging companies are increasingly using the sterilizing technique known as blow-fill-seal (BFS) for packaging and automated processes. The BFS technology has received FDA (Food and Drug Administration) certification for use in the production of pharmaceutical and healthcare products employing an improved aseptic processing technique which has created favorable market dynamics for expansion of the BFS syringe market. The demand in the market is also anticipated to be fueled by the usage of these syringes for cosmetics items in serum applications and other skincare products.
Introduction:
To offer parental preparation with very little human involvement, BFS technology has recently received great application in the pharmaceutical business. Several regulating organizations, including the US Food and Drug Administration (FDA), view this technique as a preferable approach for aseptic filling of parental preparation. Pharmaceutical packaging companies take into account several benefits of BFS syringes, including their cheap operating costs, flexible package designs, high levels of sterility, low labour demand, and small component inventories. The technology was created in Europe, where it is in high demand, followed by North America. The method is commonly used in the pharmaceutical industry to fill the parental preparation with fairly little human interference. Additionally, it is used to fill eye drops, inhalation devices, intravenous fluids, and other parent preparations. The healthcare sector's emphasis on efficiency and dose precision has sparked advancements in syringe technology. The packaging and use of syringes are changing with the introduction of blow-fill-seal (BFS) syringes. Leading syringe producers are now progressively migrating to BFS technology, which is regarded as a superior technique for aseptically filling parental preparation by several regulatory organizations which has consequently positively influenced market growth.
Drivers:
Products offered by key companies:
The prominent growth in the Polypropylene sector under the material type segment
The pharmaceutical sector captured the major market share and is predicted to dominate the market over the forecast period. Leading pharmaceutical manufacturers prevent oversights and contamination by using cutting-edge sterilization technologies. Blow-fill-seal (BFS) technology provides safe and sterile packaging, making it a popular method for medicine packaging. Leading companies use these syringes utilizing the blow-fill-seal (BFS) technology in response to the growing need for aseptic packaging in the healthcare industry. Syringes are used in healthcare to lessen the danger of contamination and dose inaccuracy. Additionally, it eliminates the chance of reuse, preventing cross-infection which as a result is a major factor driving the market growth.
European region is expected to hold a significant share of the BFS syringe market:
The European market is poised to expand significantly over the projection period. Europe is a top-tier region concerning pharmaceutical producers. The market players located in the European market are extensively involved in the export of pharma products The European market is forecasted to sustain its position as a top market for BSF syringe manufacturers. Pharmaceutical packaging industry giants have established bases in the European market, and they have a preference for blow-fill-seal technology to sterilize injectables, which serves to emphasize this even more. European-based businesses have continued to prioritize injectable packaging, which is fueling the market's explosive expansion. The demand for sophisticated aseptic packaging, such as vials, bottles, ampoules, and pre-filled syringes, is driving an increase in the use of blow-fill-seal (BFS) technology in the pharmaceutical industry.
Key developments:
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2022 | US$406.801 million |
| Growth Rate | CAGR during the forecast period |
| Base Year | 2022 |
| Forecast Period | 2024 – 2029 |
| Forecast Unit (Value) | USD Million |
| Segments Covered |
|
| Companies Covered |
|
| Regions Covered | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Customization Scope | Free report customization with purchase |
SEGMENTS: